Omega-3 Fatty Acids and Health Effects
1 other identifier
interventional
69
0 countries
N/A
Brief Summary
The investigators want to study health effects from omega-3 fatty acids, from fishoil with different quality.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Sep 2009
Shorter than P25 for not_applicable healthy
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedFirst Submitted
Initial submission to the registry
December 16, 2009
CompletedFirst Posted
Study publicly available on registry
December 17, 2009
CompletedFebruary 4, 2015
February 1, 2015
3 months
December 16, 2009
February 3, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary and secondary oxidation products
baseline (0 weeks), 3 weeks and 7 weeks
Secondary Outcomes (1)
inflammatory markers
after 0,3 and 7 weeks
Study Arms (3)
omega-3 high quality
EXPERIMENTALomega-3 low quality
EXPERIMENTALplacebo
PLACEBO COMPARATORInterventions
Capsules with omega-3 fatty acids.
Capsules with sun flower oil.
Eligibility Criteria
You may qualify if:
- Healthy individuals.
You may not qualify if:
- Pregnant women, lactating women, chronic diseases and smoking.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (4)
Myhrstad MC, Ottestad I, Gunther CC, Ryeng E, Holden M, Nilsson A, Bronner KW, Kohler A, Borge GI, Holven KB, Ulven SM. The PBMC transcriptome profile after intake of oxidized versus high-quality fish oil: an explorative study in healthy subjects. Genes Nutr. 2016 May 31;11:16. doi: 10.1186/s12263-016-0530-6. eCollection 2016.
PMID: 27551317DERIVEDMyhrstad MC, Ulven SM, Gunther CC, Ottestad I, Holden M, Ryeng E, Borge GI, Kohler A, Bronner KW, Thoresen M, Holven KB. Fish oil supplementation induces expression of genes related to cell cycle, endoplasmic reticulum stress and apoptosis in peripheral blood mononuclear cells: a transcriptomic approach. J Intern Med. 2014 Nov;276(5):498-511. doi: 10.1111/joim.12217. Epub 2014 Mar 20.
PMID: 24641624DERIVEDOttestad I, Hassani S, Borge GI, Kohler A, Vogt G, Hyotylainen T, Oresic M, Bronner KW, Holven KB, Ulven SM, Myhrstad MC. Fish oil supplementation alters the plasma lipidomic profile and increases long-chain PUFAs of phospholipids and triglycerides in healthy subjects. PLoS One. 2012;7(8):e42550. doi: 10.1371/journal.pone.0042550. Epub 2012 Aug 28.
PMID: 22952598DERIVEDOttestad I, Vogt G, Retterstol K, Myhrstad MC, Haugen JE, Nilsson A, Ravn-Haren G, Nordvi B, Bronner KW, Andersen LF, Holven KB, Ulven SM. Oxidised fish oil does not influence established markers of oxidative stress in healthy human subjects: a randomised controlled trial. Br J Nutr. 2012 Jul;108(2):315-26. doi: 10.1017/S0007114511005484. Epub 2011 Dec 5.
PMID: 22136711DERIVED
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Stine M Ulven, PhD
Oslo Metropolitan University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
December 16, 2009
First Posted
December 17, 2009
Study Start
September 1, 2009
Primary Completion
December 1, 2009
Study Completion
December 1, 2009
Last Updated
February 4, 2015
Record last verified: 2015-02